Key Highlights

  • Aeluma reported fiscal 2026 Revenue of USD 4.5 million and a net loss of USD 9.2 million, or USD 0.52 per share.
  • The company holds a letter of intent for up to USD 30 million with the US Department of Commerce CHIPS R&D Office, with definitive agreements still under negotiation.
  • Cash and cash equivalents were USD 56.0 million at 30 June 2026, helped by USD 20.1 million net raised through an at-the-market offering.

Fiscal 2026 results

Aeluma, Inc. (NASDAQ:ALMU), a Goleta, California developer of high-speed photodetectors and quantum dot lasers for AI datacom and other uses, reported fourth-quarter and full-year fiscal 2026 results on 16 September 2026. The fiscal year ended on 30 June 2026.

Fourth-quarter revenue was USD 0.6 million (USD 582,000), against USD 1.3 million a year earlier, mainly from Research and Development contracts. The net loss widened to USD 4.0 million, or USD 0.22 per share, from USD 0.9 million, or USD 0.05. Adjusted EBITDA was a loss of USD 2.9 million.

For the full year, revenue was USD 4.5 million against USD 4.7 million, mostly from government research contracts. The net loss was USD 9.2 million, or USD 0.52 per share, compared with USD 3.0 million, or USD 0.23. Management attributed the larger loss to strategic hiring and Manufacturing readiness. Full-year adjusted EBITDA was a loss of USD 5.2 million, compared with a gain of USD 0.2 million in fiscal 2025. No financial guidance or order Backlog figure was given.

CHIPS letter of intent and partnerships

The headline development was a letter of intent for up to USD 30 million with the US Department of Commerce CHIPS R&D Office, for photonics for AI and advanced computing. Definitive agreements are still under negotiation, so the funding is not yet secured.

The company also cited partnerships with Tower Semiconductor and Sumitomo Chemical Advanced Technologies, with the latter expanded to increase wafer capacity. It reported six new contracts totalling USD 5.3 million, including awards from NASA and the US Navy, and said multi-million-dollar negotiations for photonics for AI datacom were under way. Staff numbers grew from 14 to more than 30.

Chief executive Jonathan Klamkin said the AI datacom opportunity had grown significantly and that fiscal 2027 would focus on technology and product development. He added that the CHIPS funding could accelerate the commercialisation timeline. He named scalable high-speed photodetectors and quantum dot lasers as near-term product development priorities, and the company is procuring additional MOCVD tools for non-InP platforms.

Balance sheet and recent filings

Cash and cash equivalents were USD 56.0 million at 30 June 2026. The company raised USD 20.1 million net through an at-the-market offering, issuing 830,484 shares. Cash was USD 37.8 million in the prior quarter, according to the release. Total Assets were USD 60.7 million, total liabilities USD 3.7 million and stockholders' Equity USD 56.9 million. Book Value per share was USD 3.06 against USD 1.13 a year earlier.

Two later filings are worth noting. On 30 September 2026 the company reported a bylaw amendment lowering the quorum for stockholder meetings from a majority to one-third of voting power. On 22 October 2026 it reported that Dr Klamkin had terminated, on 21 October, a Rule 10b5-1 trading arrangement adopted on 23 May 2026 that provided for the sale of up to 300,000 shares. The filing gives no reason for the termination. The annual meeting is now scheduled for 19 November 2026.

What to watch

Points to watch include whether the CHIPS letter converts into definitive agreements, whether datacom negotiations become signed revenue contracts, and how quickly the company uses its cash reserves.